Aptose Biosciences Files 8-K on Security Holder Rights
Ticker: APTOF · Form: 8-K · Filed: Feb 21, 2025 · CIK: 882361
Sentiment: neutral
Topics: corporate-governance, filing, securities
Related Tickers: APTO
TL;DR
APTO filed an 8-K, changes to shareholder rights and bylaws are coming.
AI Summary
Aptose Biosciences Inc. filed an 8-K on February 21, 2025, reporting events as of February 18, 2025. The filing indicates material modifications to the rights of security holders and amendments to its articles of incorporation or bylaws. It also includes financial statements and exhibits.
Why It Matters
This 8-K filing signals potential changes affecting Aptose Biosciences' shareholders and corporate structure, requiring investor attention.
Risk Assessment
Risk Level: medium — Filings related to modifications of security holder rights and amendments to corporate bylaws can indicate significant internal changes that may impact stock value.
Key Players & Entities
- Aptose Biosciences Inc. (company) — Registrant
- 001-32001 (company) — SEC File Number
- February 18, 2025 (date) — Date of earliest event reported
- February 21, 2025 (date) — Filing Date
FAQ
What specific material modifications were made to the rights of Aptose Biosciences Inc. security holders?
The filing indicates material modifications to the rights of security holders, but the specific details of these modifications are not provided in the summary text.
Were there any amendments to Aptose Biosciences Inc.'s articles of incorporation or bylaws?
Yes, the filing explicitly states 'Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year' as an item of information.
What is the SEC file number for Aptose Biosciences Inc.?
The SEC file number for Aptose Biosciences Inc. is 001-32001.
On what date was this 8-K filing submitted?
This 8-K filing was submitted on February 21, 2025.
What is the primary business of Aptose Biosciences Inc. according to the filing?
Aptose Biosciences Inc. is in the business of 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' with SIC code [2836].
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 21, 2025 regarding Aptose Biosciences Inc. (APTOF).